RT Journal Article
SR Electronic
T1 723 Metabolically reprogrammed autologous Th1/Tc1 cell therapy (RAPA-201) yields promising safety and efficacy in post-PD-(L)1 solid tumor patients without lymphodepleting host conditioning
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A818
OP A818
DO 10.1136/jitc-2023-SITC2023.0723
VO 11
IS Suppl 1
A1 Gutierrez, Martin
A1 Donato, Michele
A1 Reich-Slotky, Ronit
A1 Patel, Sunil
A1 Finlay, Morgan
A1 Coordinator, Research Nurse
A1 Lum, Lawrence G
A1 Park, Jee Hyun
A1 Felizardo, Tania
A1 Fowler, Daniel H
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A818.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.